Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kimberly Stegmaier, M.D.

Co-Author

This page shows the publications co-authored by Kimberly Stegmaier and Pratiti Bandopadhayay.
Connection Strength

0.718
  1. A first-generation pediatric cancer dependency map. Nat Genet. 2021 04; 53(4):529-538.
    View in: PubMed
    Score: 0.241
  2. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun. 2019 06 03; 10(1):2400.
    View in: PubMed
    Score: 0.212
  3. Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling. Cancer Cell. 2018 12 10; 34(6):922-938.e7.
    View in: PubMed
    Score: 0.205
  4. Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE. Eur J Cancer. 2021 03; 146:115-124.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.